The Institute of Human Virology (IHV) and the University of Maryland School of Medicine recently appointed Lori Piccolo as Director of Development at IHV, an institute of the School of Medicine. This newly created position will lead the fundraising efforts of the IHV, the first center in the United States - perhaps the world - to combine the disciplines of basic science, epidemiology and clinical research in a concerted effort to speed the discovery of diagnostics and therapeutics for a wide variety of chronic and deadly viral and immune disorders - most notably HIV, the cause of AIDS.

“As funding for science becomes more competitive, IHV has made an effort to diversify its funding portfolio,” said Robert C. Gallo, MD, Director of the IHV and the Homer and Martha Gudelsky Distinguished Professor in Medicine. “We are pleased to have Ms. Piccolo join our team and focus her extensive expertise on fundraising for IHV.”

As Director of Development, Ms. Piccolo will develop a comprehensive fundraising program for the IHV with specific emphasis on solicitation of leadership gifts to ensure the long-term viability of this highly successful research institute. To achieve this goal, Ms. Piccolo will work in collaboration with IHV leadership to engage its Board of Advisors in fundraising activities on behalf of the Institute.

“I look forward to working with Ms. Piccolo closely and increasing IHV’s financial resources so that IHV can focus on advancing biomedical research, training the next generation of virologists and growing the Institute’s care and treatment of more than one million HIV positive patients overseas and 6,000 HIV positive Baltimoreans,” said Terry Lierman, Chairman of IHV’s Board of Advisors.

Ms. Piccolo has more than 20 years of professional experience with a range of Washington-based advocacy groups and direct service organizations focused locally, nationally, and internationally. She served in progressively responsible fundraising roles for Public Citizen, Inc., the National Museum of Health and Medicine Foundation, and People for the American Way early in her development career. Ms. Piccolo then moved onto the Washington Office on Latin America (WOLA), where she served as Director of Development and was responsible for raising more than $2 million per year. Prior to being recruited to the University of Maryland, she served as Director of Development for the Children’s Law Center, where she was instrumental in the growth of the fundraising program.

“Lori brings a wealth of talent and experience to this critical fundraising position at the Institute of Human Virology. She possesses a unique blend of major gift fundraising for international and social causes that was a wonderful match for the position in IHV,” said Brian DeFilippis, Associate Dean for Development and Special Assistant to the Dean.

Ms. Piccolo obtained her Bachelor of Arts degree in economics with a minor in Spanish from Wake Forest University. She also received a certificate in Master Gift Officer Immersion Training from the Philanthropy Leadership Advancement Nexus and is a member of the Advanced Executives Committee of the DC Chapter of the Association of Fundraising Professionals. Since 1982, Ms. Piccolo has been a member of the Executive Committee of the Chicago-based Brian Piccolo Cancer Research Fund. In 1994 she became a founding director of Human and Civil Rights Organizations of America.

About the Institute of Human Virology

Formed in 1996 as a partnership between the State of Maryland, the City of Baltimore, the University System of Maryland and the University of Maryland Medical System, IHV is an institute of the University of Maryland School of Medicine and is home to some of the most globally-recognized and world-renowned experts in all of virology. The IHV combines the disciplines of basic research, epidemiology and clinical research in a concerted effort to speed the discovery of diagnostics and therapeutics for a wide variety of chronic and deadly viral and immune disorders - most notably, HIV the virus that causes AIDS. For more information, visit www.ihv.org and follow us on Twitter @IHVmaryland.

About the University of Maryland School of Medicine

The University of Maryland School of Medicine was chartered in 1807 and is the first public medical school in the United States and continues today as an innovative leader in accelerating innovation and discovery in medicine. The School of Medicine is the founding school of the University of Maryland and is an integral part of the 11-campus University System of Maryland. Located on the University of Maryland’s Baltimore campus, the School of Medicine works closely with the University of Maryland Medical Center and Medical System to provide a research-intensive, academic and clinically based education. With 43 academic departments, centers and institutes and a faculty of more than 3,000 physicians and research scientists plus more than $400 million in extramural funding, the School is regarded as one of the leading biomedical research institutions in the U.S. with top-tier faculty and programs in cancer, brain science, surgery and transplantation, trauma and emergency medicine, vaccine development and human genomics, among other centers of excellence. The School is not only concerned with the health of the citizens of Maryland and the nation, but also has a global presence, with research and treatment facilities in more than 35 countries around the world. medschool.umaryland.edu/